Talawar Therapeutics (TLWR) JATT II Acq (JATT) deck
A biotechnology company scaling novel bispecific antibodies to shatter the clinical efficacy plateau in chronic inflammatory skin diseases via a public merger.
A biotechnology company scaling novel bispecific antibodies to shatter the clinical efficacy plateau in chronic inflammatory skin diseases via a public merger.
%20JATT%20II%20Acq%20(JATT)%20deck){kind=link}